CD273/PD-L2 Antibody (APC)

195€ (20 tests)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
CD273/PD-L2 Antibody (APC)
category
Primary Antibodies
provider
Abbexa
reference
abx229363
tested applications
FCM
Description
CD273/PD-L2 Antibody (APC) is a Human Monoclonal Antibody against CD273/PD-L2.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies | 
| Immunogen Target | CD273/PD-L2 | 
| Host | Mouse | 
| Reactivity | Human | 
| Clonality | Monoclonal | 
| Conjugation | APC | 
| Isotype | IgG2a Kappa | 
| Size 1 | 20 tests | 
| Size 2 | 100 tests | 
| Size 3 | 200 tests | 
| Tested Applications | FCM | 
| Buffer | PBS with 0.05% Proclin300, 1% BSA. | 
| Availability | Shipped within 5-15 working days. | 
| Storage | Aliquot and store at 2°C to 8°C upon receipt. Avoid exposure to light. Do not freeze. | 
| Dry Ice | No | 
| UniProt ID | Q9BQ51 | 
| Gene ID | 80380 | 
| Alias | B7DC,Btdc,PDL2,CD273,PD-L2,PDCD1L2,PD-1 ligand 2,PDCD1 ligand 2,Butyrophilin B7-DC,B7-DC | 
| Background | Antibody anti-PDCD1LG2 | 
| Status | RUO | 
Descripción
Programmed cell death 1 ligand 2 (PDCD1LG2), commonly referred to as PD-L2, is an immune regulatory protein that belongs to the B7 family of immune checkpoint ligands. PD-L2 functions as a ligand for PD-1 (Programmed Cell Death Protein 1), an inhibitory receptor on T cells, and contributes to the modulation of immune responses by promoting T cell inhibition. This ligand is highly relevant in immune tolerance, particularly in peripheral tissues where it helps prevent excessive immune reactions that could lead to tissue damage. PD-L2, together with its better-known counterpart PD-L1, plays a key role in immune escape mechanisms in cancers, where it inhibits T cell activation and proliferation, enabling tumor cells to evade immune surveillance. PD-L2 is selectively expressed on antigen-presenting cells (APCs) such as dendritic cells (DCs), macrophages, and B cells. Its expression is inducible, being upregulated under conditions of inflammation or during immune activation through signals like interleukin-4 (IL-4) and interferon-gamma (IFN-γ). This selective and inducible expression of PD-L2 suggests it has specialized roles in fine-tuning immune responses, distinguishing it from PD-L1, which is more broadly expressed across various cell types, including non-immune cells.
Related Products

APC Anti-Human CD273/PD-L2 (24F.10C12)
Ver Producto
Human PDCD1LG2 (Programmed Cell Death Protein 1 Ligand 2) ELISA Kit
Ver Producto